PD-L1 antibody (Isoform 1)
Quick Overview for PD-L1 antibody (Isoform 1) (ABIN6990335)
Target
See all PD-L1 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 60-110, Isoform 1
-
Specificity
- PD-L1 antibody has no cross-reactivity to PD-L2.
-
Purification
- PD-L1 Antibody is affinity chromatography purified via peptide column.
-
Immunogen
- Anti-PD-L1 antibody was raised against a peptide corresponding to 17 amino acids near the center of human PD-L1 isoform 1. The immunogen is located within amino acids 60 - 110 of PD-L1.
-
Isotype
- IgG
-
-
-
-
Application Notes
-
WB: 1-2 μ,g/mL, IHC-P: 2.5-5 μ,g/mL, IF: 20 μ,g/mL, Flow Cyt: 0.5 μ,g/mL.
Antibody validated: Western Blot in human and mouse samples, Immunohistochemistry in human and rat samples, Immunofluorescence in human and rat samples and Flow Cytometry in mouse samples. All other applications and species not yet tested. -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- PD-L1 Antibody is supplied in PBS containing 0.02 % sodium azide.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C,4 °C
-
Storage Comment
- PD-L1 antibody can be stored at 4°C for three months and -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
-
-
- PD-L1 (CD274 (PD-L1))
-
Alternative Name
- PD-L1
-
Background
- PD-L1 plays a critical role in induction and maintenance of immune tolerance to self. As a ligand for the inhibitory receptor PDCD1/CD279, PD-L1 modulates the activation threshold of T-cells and limits T-cell effector response (1). The PDCD1/CD279-mediated inhibitory pathway is exploited by tumors to attenuate anti-tumor immunity and facilitate tumor survival (2,3). Through a yet unknown activating receptor, it may costimulate T-cell subsets that predominantly produce interleukin-10 (IL10) (4).
-
Molecular Weight
-
Predicted: 33 kDa
Observed: 37 kDa -
Gene ID
- 29126
-
NCBI Accession
- NP_054862
-
UniProt
- Q9NZQ7
-
Pathways
- Cancer Immune Checkpoints
Target
-